O001 Randomized, double-blind, placebo-controlled trial of recombinant human C1 inhibitor for prophylaxis of hereditary angioedema attacks

Authors :: Roman Hakl
Dumitru Moldovan
Avner Reshef
Marco Cicardi
Joseph R. Harper
Anurag Relan
William H. Yang
Richard F. Lockey
Marc A. Riedl
Shmuel Kivity
L. Bellizzi
Sladjana Andrejevic
James R. Baker
V. Grivcheva Panovska
Source :: Annals of Allergy, Asthma & Immunology. 117:S1
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Pulmonary and Respiratory Medicine
medicine.medical_specialty
business.industry
Immunology
Placebo-controlled study
medicine.disease
Gastroenterology
Double blind
Internal medicine
Hereditary angioedema
Recombinant human C1 inhibitor
medicine
Immunology and Allergy
business

Full Text Access

Tools